跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,994 条关于
“Umoja BioPharma”
全部
1,994
临床试验
9
药物
397
机构
202
资讯
1,386
10个月前
Nona Biosciences Expands CAR-T Partnership with Umoja Biopharma to Develop In Vivo Cell Therapies
4个月前
Umoja Biopharma Unveils Industry's First Dual-Targeted BCMA x GPRC5D In Vivo CAR T Therapy for Multiple Myeloma
11个月前
FDA Grants Fast Track Designation to UB-VV111, First In Vivo CAR-T Therapy for Relapsed B-Cell Malignancies
去年
AbbVie Acquires In Vivo CAR-T Developer Capstan Therapeutics for Up to $2.1 Billion
去年
Pharma VC Investments Reach $6.5 Billion in Q1 2025 with Oncology Leading the Pack
去年
Allogeneic Cell Therapies Emerge as Next-Generation Cancer Treatment to Address Manufacturing and Cost Challenges
前天
FDA Clears IND for IASO208, First China-Originated In Vivo CAR-T to Enter US Clinic
2年前
In Vivo CAR T-Cell Therapies Advance to Clinical Trials, Promising Faster, Cheaper Cancer Treatment
2年前
Immix Biopharma's NXC-201 Shows Promise as Outpatient CAR-T Therapy in Amyloidosis and Multiple Myeloma
3个月前
India Launches Biopharma SHAKTI Initiative, Targets 100 Biologics by 2047 to Become Global Biopharma Hub
第 1 页,共 139 页
上一页
下一页